ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Raise Cigarette Taxes, Fully Fund Bypass Budget, Increase Biomedical research Support, NCAB Urges

October 6, 1989

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

June 16, 1989

Carlson Named NCCN Chief Executive

September 28, 2012